Clinical studies recruiting near Homewood

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

A Phase 3 Single-arm Study of UGN-104 for the Treatment of Low-grade Upper Tract Urothelial Cancer
Phase 3 · Urology Centers of Alabama · UroGen Pharma Ltd. · NCT06774131 A Study to Test the Effects and Safety of Riliprubart in People With Chronic Inflammatory Demyelinating Polyneuropathy (
Phase 3 · Alabama Neurology Associates- Site Number : 8400019 · Sanofi · NCT06290128 Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder
Phase 2 · Urology Centers of Alabama · Protara Therapeutics · NCT05951179 FOLFIRI and Bevacizumab With or Without Pelareorep for Second-Line Treatment of Metastatic RAS-Mutated, Microsatellite-S
Phase 2 · Central Alabama Research · Oncolytics Biotech · NCT07446322 A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
Phase 3 · 89bio Clinical Study Site · 89bio, Inc. · NCT06419374 Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Particip
Phase 3 · Alabama Neurology Associates- Site Number : 8400115 · Sanofi · NCT07325292 Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associate
Phase 3 · Local Institution - 1029 · Karuna Therapeutics, Inc., a Bristol Myers Squibb company · NCT05980949 Copper Cu 64 PSMA I&T PET Imaging in Men With Newly Diagnosed Prostate Cancer
Phase 3 · Urology Centers of Alabama · Curium US LLC · NCT06235151 A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT
Phase 3 · Local Institution - 1029 · Karuna Therapeutics, Inc., a Bristol Myers Squibb company · NCT05511363 Post Approval Effectiveness and Durability Evaluation of the Altaviva™ Tibial Device
NA · Urology Centers of Alabama · MedtronicNeuro · NCT07456865 Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants W
Phase 2 · Local Institution - 0046 · Celgene · NCT06808984 A Real World Study of eCoin for Urgency Urinary Incontinence: Post Approval Evaluation (RECIPE)
NA · Urology Centers of Alabama · Valencia Technologies Corporation · NCT05685433 Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
Phase 3 · Urology Centers Of Alabama Pc · Novartis Pharmaceuticals · NCT06855277 A Study to Test the Efficacy and Safety of Riliprubart Against the Usual Treatment of Intravenous Immunoglobulin (IVIg)
Phase 3 · Alabama Neurology Associates- Site Number : 8400019 · Sanofi · NCT06290141 Efficacy and Safety of TYRA-300 in Participants With FGFR3 Altered Low Grade, Intermediate Risk Non-Muscle Invasive Blad
Phase 2 · Urology Centers of Alabama · Tyra Biosciences, Inc · NCT06995677 Study of DONQ52 in Active Celiac Disease
Phase 2 · Birmingham Digestive Health Research · Chugai Pharmaceutical · NCT07239336 Study to Assess the Impact of the Urine Test Cxbladder Triage Plus on the Number of Cystoscopies Performed on Patients W
NA · Urology Centers of Alabama · Pacific Edge Limited · NCT06394869 A Study to Assess the Effectiveness and Safety of IPN10200 in Adults With Moderate to Severe Wrinkle-like Lines Between
Phase 3 · Ipsen · NCT07427797

Look up another city

Look up another condition